Home » National Health Research Forum » 2011 National Health Research Forum

2011 National Health Research Forum

Building Our Nation’s Economy and Health Through Medical Research

March 15, 2011

Our National Health Research Forum engages leaders in government, industry, academia, patient advocacy organizations and the media in a dialogue concerning key medical, health and scientific research issues. Click below for the full audio of the event. (If you have trouble, please visit our podcast site for smaller versions of the audio file.)

A National Discussion on Research

The 2011 National Health Research Forum will include two panel discussions.

The first panel was moderated by Michael Riley, managing editor at Bloomberg Government. Panelists include Carolyn M. Clancy, MD, director of the Agency for Healthcare Research and Quality; Victor Dzau, MD, chancellor for health affairs at Duke University and president and CEO of Duke University Health System; Thomas R. Frieden, MD, MPH, director of the Centers for Disease Control and Prevention; and Harry Johns, president and CEO of the Alzheimer’s Association.

The second panel was moderated by Clive Crook, senior editor at The Atlantic . Panelists include John J. Castellani, president and CEO of PhRMA; Francis S. Collins, MD, PhD, director of the National Institutes of Health; MargaretA. Hamburg, MD, commissioner of theFood and Drug Administration; David C. Page, MD, director of the Whitehead Institute for Biomedical Research; Ellen Sigal, PhD, chair and founder of Friends of Cancer Research; and The Honorable Mike Castle.

Forum participants engage in dynamic discussions with each other and the audience about research to improve health. Through our forum they have an opportunity to:

  • Discuss the issues driving the national agenda for medical and health research
  • Understand strategies for winning greater influence for science.
  • Hear experts address complicated issues that influence public policy, media coverage and public perception.
  • Take part in a question and answer session with the panelist speakers.
  • Network with top leaders and other like-minded stakeholders in research.